The Drug-Induced Respiratory Disease Website

I - Cardiac arrhythmia(s)/dysrhythmia(s) (AF, VT, VF, TdP) - QTc prolongation)

I.l

Cardiac- cardiorespiratory/pulmonary arrest

1

Evidence level

low

X - Pulmonary edema

X.b

Pulmonary edema, noncardiogenic (NCPE)

2

Evidence level

possible

X.d

Fluid retention

1

Evidence level

low

XIII - Thrombosis - Embolism

XIII.f

Fat/oil embolism - The FES embolism syndrome

1

Evidence level

low

XV - Chest pain

XV.a

Chest pain (acute or subacute), lone or prominent

1

Evidence level

low

XXII - Acute respiratory/cardiorespiratory failure

XXII.b

Acute lung injury - ARDS

2

Evidence level

possible

XXIV - Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis

XXIV.j

Organizing pneumonia (OP/BOOP) pattern (an area or areas of consolidation on imaging)

1

Evidence level

low

XXIX - Small airway involvement

XXIX.a

Bronchospasm - Wheezing - Asthma

1

Evidence level

low

XXXIII - Histopathology (for pulmonary pathology see in ‘Pneumotox’ (a free companion App)

XXXIII.o

Path: Lipid/fat embolism

1

Evidence level

low

XXXVI - Autoimmune syndromes - Systemic reactions or conditions

XXXVI.f

Anaphylaxis - Anaphylactoid reaction (either of these can be fatal)

2

Evidence level

possible

XXXVIII - Miscellaneous - Varia

XXXVIII.a

Upper airway obstruction other than angioedema or hematoma

1

Evidence level

low

XXXVIII.k

Hypersensitivity reaction (may manifest with fever and/or skin, throat or airway involvement)

2

Evidence level

possible